In addition, both TSA [8] and valproic acid [9] HDAC inhibitors improve morphology and function of skeletal muscle in DMD mouse models - positive effects accredited to the upregulation of follistatin or Akt signaling pathways, respectively. The gene discussed is FST; the disease is Duchenne muscular dystrophy.